Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000688

Drug Information
NameHexobarbital
SynonymsNSC71929; Barbituric acid, 5-(1-cyclohexen-1-yl)-1,5-dimethyl-; CID3608; C11723; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohexen-1-yl)-1,5-dimethyl-, (+-)-; Evipan; Methylhexabital; 5-(.delta.-1,2-cyclohexenyl)-5-methyl-N-methyl-barbitursaeure; 5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione; Hexobarbital [INN:JAN]; 5-cyclohex-1-en-1-yl-2-hydroxy-1,5-dimethylpyrimidine-4,6(1H,5H)-dione; 5-(delta-1,2-cyclohexenyl)-5-methyl-N-methyl-barbitursaeure; Sombucaps; Hexobarbital; Enhexymal; NCGC00159430-02; Noctivane; MolPort-001-783-664; LS-24041; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohexen-1-yl)-1,5-dimethyl-; AI3-61892; Enhexymalum; 5-(1-Cyclohexenyl-1)-1-methyl-5-methylbarbituric acid; Oprea1_350917; Cyclopan; Cyclonal; 5-(1-CYCLOHEXEN-1-YL)-1,5-DIMETHYLBARBITURIC ACID; Sombulex; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohexen-1-yl)-1,5-dimethyl; 1,5-Dimethyl-5-(1-cyclohexenyl)barbituric acid; AC1L1GB8; AKOS000355976; 5-cyclohex-1-en-1-yl-1,5-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione; Somnalert; Hexobarbitalum; 5-(cyclohexen-1-yl)-1,5-dimethyl-1,3-diazinane-2,4,6-trione; 5-(1-Cyclohexenyl)-1,5-dimethylbarbituric acid; MolPort-002-070-456; N-Methyl-5-cyclohexenyl-5-methylbarbituric acid; Evipal; (+-)-Hexobarbital; H1005_SIGMA; STK696034; Esobarbitale [DCIT]; H1005_FLUKA; Hexenal (barbiturate); Methexenyl; 5-(delta-1,2-Cyclohexenyl)-5-methyl-N-methyl-barbitursaeure [German]; Dorico; MLS001143909; 7200-11-5; 5-(cyclohex-1-en-1-yl)-1,5-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione; Barbidorm; Methylhexabarbital; Hexobarbital (VAN); D01071; Hexobarbitonum; Esobarbitale [Italian]; WLN: T6VMVNV FHJ D1 F1 F- AL6UTJ; Hexobarbital (JAN/INN); Hexanastab oral; Narcosan; Hexobarbitalum [INN-Latin]; Citopan; UNII-AL8Z8K3P6S; NSC 71929; NCGC00159430-03; Hexobarbitone; 56-29-1; DB01355; CHEMBL7728; EINECS 200-264-9; Sodium hexobarbital; Citodon; Hexabarbital; SMR000473348; AC-16076; CHEBI:5706; Esobarbitale
Trade NameCitopan; Evipan
IndicationAnesthetic
[ICD9: 338   ICD10: R52]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H
,3-5,7H2,1-2H3,(H,13,15,17)
InChIKeyUYXAWHWODHRRMR-UHFFFAOYSA-N
Canonical SMILESCC1(C(=O)NC(=O)N(C1=O)C)C2=CCCCC2    
Therapeutic ClassHypnotics and Sedatives
CAS NumberCAS 56-29-1
FormulaC12H16N2O3
PubChem Compound IDCID 3608.
PubChem Substance IDSID 13888.
ChEBI5706;
SuperDrug ATC IDN01AF02; N05CA16
SuperDrug CAS ID000056291;
TargetGamma-aminobutyric acid receptor subunit alpha-1Antagonist[2][3]
Ref 1Drug information of Hexobarbital, 2008 To Reference
Ref 2DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6. Epub 2007 Nov 29. To Reference
Ref 3Effect of barbiturates on polyphosphoinositide biosynthesis and protein kinase C activity in synaptosomes. Neuropharmacology. 1989 Dec;28(12):1317-23. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543